24 research outputs found

    Pose-Guided High-Resolution Appearance Transfer via Progressive Training

    Full text link
    We propose a novel pose-guided appearance transfer network for transferring a given reference appearance to a target pose in unprecedented image resolution (1024 * 1024), given respectively an image of the reference and target person. No 3D model is used. Instead, our network utilizes dense local descriptors including local perceptual loss and local discriminators to refine details, which is trained progressively in a coarse-to-fine manner to produce the high-resolution output to faithfully preserve complex appearance of garment textures and geometry, while hallucinating seamlessly the transferred appearances including those with dis-occlusion. Our progressive encoder-decoder architecture can learn the reference appearance inherent in the input image at multiple scales. Extensive experimental results on the Human3.6M dataset, the DeepFashion dataset, and our dataset collected from YouTube show that our model produces high-quality images, which can be further utilized in useful applications such as garment transfer between people and pose-guided human video generation.Comment: 10 pages, 10 figures, 2 table

    Phase I trial of vinflunine and pemetrexed in refractory solid tumors

    Get PDF
    Vinflunine is a novel vinca alkaloid with promising single agent clinical activity. Pemetrexed has at least additive activity with other vincas. A phase I trial was undertaken to assess the safety of vinflunine and pemetrexed in patients with refractory solid tumors

    A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors

    Get PDF
    Epidermal growth factor receptor (EGFR) inhibition may overcome chemotherapy resistance by inhibiting important anti-apoptotic signals that are constitutively activated by an overstimulated EGFR pathway

    Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

    Get PDF
    Based on preclinical studies and a phase I trial of the combination of bortezomib and pegylated liposomal doxorubicin (PLD), which both showed activity in breast cancer, we conducted a phase II study of this regimen in patients with metastatic breast cancer

    Risk factors associated with surgical site infections following joint replacement surgery: a narrative review

    No full text
    Abstract Background Surgical site infection following joint replacement surgery is still a significant complication, resulting in repeated surgery, prolonged antibiotic therapy, extended postoperative hospital stay, periprosthetic joint infection, and increased morbidity and mortality. This review discusses the risk factors associated with surgical site infection. Related risk factors The patient-related factors include sex, age, body mass index (BMI), obesity, nutritional status, comorbidities, primary diagnosis, living habits, and scores of the American Society of Anesthesiologists physical status classification system, etc. Surgery-related factors involve preoperative skin preparation, prolonged duration of surgery, one-stage bilateral joint replacement surgery, blood loss, glove changes, anti-microbial prophylaxis, topical anti-bacterial preparations, wound management, postoperative hematoma, etc. Those risk factors are detailed in the review. Conclusion Preventive measures must be taken from multiple perspectives to reduce the incidence of surgical site infection after joint replacement surgery
    corecore